From Pluripotency to Distinct Cardiomyocyte Subtypes

Physiology

Volumn 27, Issue 3, 2012, Pages 119-129

  David, Robert ^a   Franz, Wolfgang Michael ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CELL DIFFERENTIATION; CYTOLOGY; EMBRYONIC STEM CELL; HEART MUSCLE CELL; HUMAN; PLURIPOTENT STEM CELL; REVIEW; STEM CELL TRANSPLANTATION; TRANSPLANTATION;

ADULT; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; HUMANS; MYOCYTES, CARDIAC; PLURIPOTENT STEM CELLS; STEM CELL TRANSPLANTATION;

EID: 84862203224     PISSN: 15489213     EISSN: 15489221     Source Type: Journal    
DOI: 10.1152/physiol.00044.2011     Document Type: Review

References (137)

1. Anokye-Danso F, Trivedi CM, Juhr D, Gupta M, Cui Z, Tian Y, Zhang Y, Yang W, Gruber PJ, Epstein JA, Morrisey EE. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 8: 376-388, 2011.
2. Azpiazu N, Frasch M. Tinman and bagpipe: two homeo box genes that determine cell fates in the dorsal mesoderm of Drosophila. Genes Dev 7: 1325-1340, 1993.
3. Bar-Nur O, Russ HA, Efrat S, Benvenisty N. Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. Cell Stem Cell 9: 17-23, 2011.
4. Behfar A, Perez-Terzic C, Faustino RS, Arrell DK, Hodgson DM, Yamada S, Puceat M, Niederlander N, Alekseev AE, Zingman LV, Terzic A. Cardiopoietic programming of embryonic stem cells for tumor-free heart repair. J Exp Med 204: 405-420, 2007.
5. Bodmer R. The gene tinman is required for specification of the heart and visceral muscles in Drosophila. Development 118: 719-729, 1993.
6. Boland MJ, Hazen JL, Nazor KL, Rodriguez AR, Gifford W, Martin G, Kupriyanov S, Baldwin KK. Adult mice generated from induced pluripotent stem cells. Nature 461: 91-94, 2009.
7. Bondue A, Blanpain C. Mesp1: a key regulator of cardiovascular lineage commitment. Circ Res 107: 1414-1427, 2010.
8. Bondue A, Lapouge G, Paulissen C, Semeraro C, Iacovino M, Kyba M, Blanpain C. Mesp1 acts as a master regulator of multipotent cardiovascular progenitor specification. Cell Stem Cell 3: 69-84, 2008.
9. Bondue A, Tannler S, Chiapparo G, Chabab S, Ramialison M, Paulissen C, Beck B, Harvey R, Blanpain C. Defining the earliest step of cardiovascular progenitor specification during embryonic stem cell differentiation. J Cell Biol 192: 751-765, 2011.
10. Boyle A, Colvin-Adams M. Recipient selection and management. Semin Thorac Cardiovasc Surg 16: 358-363, 2004.
11. Byrne JA, Pedersen DA, Clepper LL, Nelson M, Sanger WG, Gokhale S, Wolf DP, Mitalipov SM. Producing primate embryonic stem cells by somatic cell nuclear transfer. Nature 450: 497-502, 2007.
12. Caspi O, Huber I, Kehat I, Habib M, Arbel G, Gepstein A, Yankelson L, Aronson D, Beyar R, Gepstein L. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myo-cardial performance in infarcted rat hearts. J Am Coll Cardiol 50: 1884-1893, 2007.
13. Chen JN, Fishman MC. Zebrafish tinman ho-molog demarcates the heart field and initiates myocardial differentiation. Development 122: 3809-3816, 1996.
14. Chin MH, Mason MJ, Xie W, Volinia S, Singer M, Peterson C, Ambartsumyan G, Aimiuwu O, Rich-ter L, Zhang J, Khvorostov I, Ott V, Grunstein M, Lavon N, Benvenisty N, Croce CM, Clark AT, Baxter T, Pyle AD, Teitell MA, Pelegrini M, Plath K, Lowry WE. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 5: 111-123, 2009.
15. Costello I, Pimeisl IM, Drager S, Bikoff EK, Robertson EJ, Arnold SJ. The T-box transcription factor Eomesodermin acts upstream of Mesp1 to specify cardiac mesoderm during mouse gastru-lation. Nat Cell Biol 13: 1084-1091, 2011.
16. David R, Brenner C, Stieber J, Schwarz F, Brunner S, Vollmer M, Mentele E, Muller-Hocker J, Kita-jima S, Lickert H, Rupp R, Franz WM. MesP1 drives vertebrate cardiovascular differentiation through Dkk-1-mediated blockade of Wnt-signal-ling. Nat Cell Biol 10: 338-345, 2008.
17. David R, Groebner M, Franz WM. Magnetic cell sorting purification of differentiated embryonic stem cells stably expressing truncated human CD4 as surface marker. Stem Cells 23: 477-482, 2005.
18. David R, Jarsch VB, Schwarz F, Nathan P, Gegg M, Lickert H, Franz WM. Induction of MesP1 by Brachyury(T) generates the common multipotent cardiovascular stem cell. Cardiovasc Res 92: 115-122, 2011.
19. David R, Stieber J, Fischer E, Brunner S, Brenner C, Pfeiler S, Schwarz F, Franz WM. Forward programming of pluripotent stem cells towards distinct cardiovascular cell types. Cardiovasc Res 84: 263-272, 2009.
20. Davis RL, Cheng PF, Lassar AB, Thayer M, Tap-scott S, Weintraub H. MyoD and achaete-scute: 4-5 amino acids distinguishes myogenesis from neurogenesis. Princess Takamatsu Symp 20: 267-278, 1989.
21. Deng J, Shoemaker R, Xie B, Gore A, LeProust EM, Antosiewicz-Bourget J, Egli D, Maherali N, Park IH, Yu J, Daley GQ, Eggan K, Hochedlinger K, Thomson J, Wang W, Gao Y, Zhang K. Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear repro-gramming. Nat Biotechnol 27: 353-360, 2009.
22. Dey D, Evans GR. Generation of induced pluripo-tent stem (iPS) cells by nuclear reprogramming. Stem Cells Int 2011: 619583, 2011.
23. Durocher D, Chen CY, Ardati A, Schwartz RJ, Nemer M. The atrial natriuretic factor promoter is a downstream target for Nkx-2.5 in the myocardium. Mol Cell Biol 16: 4648-4655, 1996.
24. Efe JA, Hilcove S, Kim J, Zhou H, Ouyang K, Wang G, Chen J, Ding S. Conversion of mouse fibroblasts into cardiomyocytes using a direct re-programming strategy. Nat Cell Biol 13: 215-222, 2011.
25. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature 292: 154-156, 1981.
26. Filipczyk AA, Passier R, Rochat A, Mummery CL. Regulation of cardiomyocyte differentiation of embryonic stem cells by extracellular signalling. Cell Mol Life Sci 64: 704-718, 2007.
27. Forouhar AS, Liebling M, Hickerson A, Nasiraei-Moghaddam A, Tsai HJ, Hove JR, Fraser SE, Dickinson ME, Gharib M. The embryonic vertebrate heart tube is a dynamic suction pump. Science 312: 751-753, 2006.
28. Frantz RP, Olson LJ. Recipient selection and management before cardiac transplantation. Am J Med Sci 314: 139-152, 1997.
29. Gai H, Leung EL, Costantino PD, Aguila JR, Nguyen DM, Fink LM, Ward DC, Ma Y. Generation and characterization of functional cardiomy-ocytes using induced pluripotent stem cells derived from human fibroblasts. Cell Biol Int 33: 1184-1193, 2009.
30. Galli D, Innocenzi A, Staszewsky L, Zanetta L, Sam-paolesi M, Bai A, Martinoli E, Carlo E, Balconi G, Fiordaliso F, Chimenti S, Cusella G, Dejana E, Cossu G, Latini R. Mesoangioblasts, vessel-associated mul-tipotent stem cells, repair the infarcted heart by multiple cellular mechanisms: a comparison with bone marrow progenitors, fibroblasts, and endo-thelial cells. Arterioscler Thromb Vasc Biol 25: 692-697, 2005.
31. Gaur M, Ritner C, Sievers R, Pedersen A, Prasad M, Bernstein HS, Yeghiazarians Y. Timed inhibition of p38MAPK directs accelerated differentiation of human embryonic stem cells into cardiomyocytes. Cy-totherapy 12: 807-817, 2010.
32. Geron Corporation. World's first clinical trial of human embryonic stem cell therapy cleared. Re-gen Med 4: 161, 2009.
33. Gessert S, Kuhl M. The multiple phases and faces of wnt signaling during cardiac differentiation and development. Circ Res 107: 186-199, 2010.
34. Ghosh Z, Wilson KD, Wu Y, Hu S, Quertermous T, Wu JC. Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells. PLos One 5: e8975, 2010.
35. Graichen R, Xu X, Braam SR, Balakrishnan T, Norfiza S, Sieh S, Soo SY, Tham SC, Mummery C, Colman A, Zweigerdt R, Davidson BP. Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK. Differentiation 76: 357-370, 2008.
36. Gurdon JB, Byrne JA, Simonsson S. Nuclear re-programming and stem cell creation. Proc Natl Acad Sci USA 100, Suppl 1: 11819-11822, 2003.
37. Habets PE, Moorman AF, Clout DE, van Roon MA, Lingbeek M, van Lohuizen M, Campione M, Christoffels VM. Cooperative action of Tbx2 and Nkx2.5 inhibits ANF expression in the atrioven-tricular canal: implications for cardiac chamber formation. Genes Dev 16: 1234-1246, 2002.
38. Halder G, Callaerts P, Gehring WJ. Induction of ectopic eyes by targeted expression of the eyeless gene in Drosophila. Science 267: 1788-1792, 1995.
39. Hao J, Daleo MA, Murphy CK, Yu PB, Ho JN, Hu J, Peterson RT, Hatzopoulos AK, Hong CC. Dor-somorphin, a selective small molecule inhibitor of BMP signaling, promotes cardiomyogenesis in embryonic stem cells. PLos One 3: e2904, 20 08.
40. Harvey RP. NK-2 homeobox genes and heart development. Dev Biol 178:.203-216, 1996.
41. Hescheler J, Fleischmann BK, Lentini S, Maltsev VA, Rohwedel J, Wobus AM, Addicks K. Embryonic stem cells: a model to study structural and functional properties in cardiomyogenesis. Car-diovasc Res 36:.149-162, 1997.
42. Hochedlinger K, Plath K. Epigenetic reprogram-ming and induced pluripotency. Development 136: 509-523, 2009.
43. Hochedlinger K, Rideout WM, Kyba M, Daley GQ, Blelloch R, Jaenisch R. Nuclear transplantation, embryonic stem cells and the potential for cell therapy. Hematol J 5, Suppl 3: S114-S117, 2004.
44. Hove JR, Koster RW, Forouhar AS, Acevedo-Bolton G, Fraser SE, Gharib M. Intracardiac fluid forces are an essential epigenetic factor for embryonic cardiogenesis. Nature 421: 172-177, 2003.
45. Hu Q, Friedrich AM, Johnson LV, Clegg DO. Memory in induced pluripotent stem cells: repro-grammed human retinal-pigmented epithelial cells show tendency for spontaneous redifferentiation. Stem Cells 28: 1981-1991, 2010.
46. Hunt SA. Current status of cardiac transplantation. JAMA 280: 1692-1698, 1998.
47. Hutcheson KA, Atkins BZ, Hueman MT, Hopkins MB, Glower DD, Taylor DA. Comparison of benefits on myocardial performance of cellular car-diomyoplasty with skeletal myoblasts and fibroblasts. Cell Transplant 9: 359-368, 2000.
48. Ieda M, Fu JD, Delgado-Olguin P, Vedantham V, Hayashi Y, Bruneau BG, Srivastava D. Direct re-programming of fibroblasts into functional cardi-omyocytes by defined factors. Cell 142: 375-386, 2010.
49. Inga A, Reamon-Buettner SM, Borlak J, Resnick MA. Functional dissection of sequence-specific NKX2-5 DNA binding domain mutations associated with human heart septation defects using a yeast-based system. Hum Mol Genet 14: 1965-1975, 2005.
50. Islas J, Schwartz R. Generation of cardiac progenitors by ETS-2 and MesP1 from normal human dermal fibroblasts. In: Keystone Symposium: Mechanisms of Cardiac Growth, Death and Regeneration. Keystone, CO: Keystone Symposia, 2011.
51. Izumi N, Era T, Akimaru H, Yasunaga M, Ni-shikawa S. Dissecting the molecular hierarchy for mesendoderm differentiation through a combination of embryonic stem cell culture and RNA interference. Stem Cells 25: 1664-1674, 2007.
52. Jandial R, Levy ML. Cellular alchemy: induced pluripotent stem cells retain epigenetic memory. World Neurosurg 75: 5-6, 2011.
53. Kasahara H, Usheva A, Ueyama T, Aoki H, Horikoshi N, Izumo S. Characterization of homo-and heterodimerization of cardiac Csx/Nkx2.5 homeoprotein. J Biol Chem 276: 4570-4580, 2001.
54. Kattman SJ, Koonce CH, Swanson BJ, Anson BD. Stem cells and their derivatives: a renaissance in cardiovascular translational research. J Cardio-vasc Transl Res 4: 66-72, 2011.
55. Kessler PD, Byrne BJ. Myoblast cell grafting into heart muscle: cellular biology and potential applications. Annu Rev Physiol 61: 219-242, 1999.
56. Kim K, Doi A, Wen B, Ng K, Zhao R, Cahan P, Kim J, Aryee MJ, Ji H, Ehrlich LI, Yabuuchi A, Takeu-chi A, Cunniff KC, Hongguang H, McKinney-Freeman S, Naveiras O, Yoon TJ, Irizarry RA, Jung N, Seita J, Hanna J, Murakami P, Jaenisch R, Weissleder R, Orkin SH, Weissman IL, Feinberg AP, Daley GQ. Epigenetic memory in induced pluripotent stem cells. Nature 467: 285-290, 2010.
57. Kim Y, Nirenberg M. Drosophila NK-homeobox genes. Proc Natl Acad Sci USA 86: 7716-7720, 1989.
58. Kitajima S, Takagi A, Inoue T, Saga Y. MesP1 and MesP2 are essential for the development of cardiac mesoderm. Development 127: 3215-3226, 2000.
59. Korewicki J. Cardiac transplantation is still the method of choice in the treatment of patients with severe heart failure. Cardiol J 16: 493-499, 2009.
60. Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, Dupras SK, Reinecke H, Xu C, Hassanipour M, Police S, O'Sullivan C, Collins L, Chen Y, Minami E, Gill EA, Ueno S, Yuan C, Gold J, Murry CE. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Bio-technol 25: 1015-1024, 2007.
61. Laflamme MA, Zbinden S, Epstein SE, Murry CE. Cell-based therapy for myocardial ischemia and infarction: pathophysiological mechanisms. Annu Rev Pathol 2: 307-339, 2007.
62. Lahmers S, Wu Y, Call DR, Labeit S, Granzier H. Developmental control of titin isoform expression and passive stiffness in fetal and neonatal myocardium. Circ Res 94: 505-513, 2004.
63. Lammerding J, Lee RT. Mechanical properties of interphase nuclei probed by cellular strain application. Methods Mol Biol 464: 13-26, 2009.
64. Lammerding J, Schulze PC, Takahashi T, Kozlov S, Sullivan T, Kamm RD, Stewart CL, Lee RT. Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction. J Clin Invest 113: 370-378, 2004.
65. Laurent LC, Ulitsky I, Slavin I, Tran H, Schork A, Morey R, Lynch C, Harness JV, Lee S, Barrero MJ, Ku S, Martynova M, Semechkin R, Galat V, Got-tesfeld J, Izpisua Belmonte JC, Murry C, Kei-rstead HS, Park HS, Schmidt U, Laslett AL, Muller FJ, Nievergelt CM, Shamir R, Loring JF. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 8: 106-118, 2011.
66. Linask KK, Han MD, Linask KL, Schlange T, Brand T. Effects of antisense misexpression of CFC on downstream flectin protein expression during heart looping. Dev Dyn 228: 217-230, 2003.
67. Linask KK, Yu X, Chen Y, Han MD. Directionality of heart looping: effects of Pitx2c misexpression on flectin asymmetry and midline structures. Dev Biol 246: 407-417, 2002.
68. Lindsley RC, Gill JG, Murphy TL, Langer EM, Cai M, Mashayekhi M, Wang W, Niwa N, Nerbonne JM, Kyba M, Murphy KM. Mesp1 coordinately regulates cardiovascular fate restriction and epi-thelial-mesenchymal transition in differentiating ESCs. Cell Stem Cell 3: 55-68, 2008.
69. Lints TJ, Parsons LM, Hartley L, Lyons I, Harvey RP. Nkx-2.5: a novel murine homeobox gene expressed in early heart progenitor cells and their myogenic descendants. Development 119: 969, 1993.
70. Lister R, Pelizzola M, Kida YS, Hawkins RD, Nery JR, Hon G, Antosiewicz-Bourget J, O'Malley R, Castanon R, Klugman S, Downes M, Yu R, Stewart R, Ren B, Thomson JA, Evans RM, Ecker JR. Hotspots of aberrant epigenomic reprogram-ming in human induced pluripotent stem cells. Nature 471: 68-73, 2011.
71. Lu W, Seeholzer SH, Han M, Arnold AS, Serrano M, Garita B, Philp NJ, Farthing C, Steele P, Chen J, Linask KK. Cellular nonmuscle myosins NMHC-IIA and NMHC-IIB and vertebrate heart looping. Dev Dyn 237: 3577-3590, 2008.
72. Lyons I, Parsons LM, Hartley L, Li R, Andrews JE, Robb L, Harvey RP. Myogenic and morphoge-netic defects in the heart tubes of murine embryos lacking the homeo box gene Nkx2-5. Genes Dev 9: 1654-1666, 1995.
73. Madonna R. Human-induced pluripotent stem cells: in quest of clinical applications. Mol Bio-technol 2012.
74. Maltsev VA, Rohwedel J, Hescheler J, Wobus AM. Embryonic stem cells differentiate in vitro into cardiomyocytes representing sinusnodal, atrial and ventricular cell types. Mech Dev 44: 41-50, 1993.
75. Maltsev VA, Wobus AM, Rohwedel J, Bader M, Hescheler J. Cardiomyocytes differentiated in vitro from embryonic stem cells developmentally express cardiac-specific genes and ionic currents. Circ Res 75: 233-244, 1994.
76. Mammoto T, Ingber DE. Mechanical control of tissue and organ development. Development 137: 1407-1420, 2010.
77. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA 78: 7634-7638, 1981.
78. Martinez-Fernandez A, Nelson TJ, Yamada S, Reyes S, Alekseev AE, Perez-Terzic C, Ikeda Y, Terzic A. iPS programmed without c-MYC yield proficient cardiogenesis for functional heart chi-merism. Circ Res 105: 648-656, 2009.
79. Mauritz C, Schwanke K, Reppel M, Neef S, Kat-sirntaki K, Maier LS, Nguemo F, Menke S, Haust-ein M, Hescheler J, Hasenfuss G, Martin U. Generation of functional murine cardiac myo-cytes from induced pluripotent stem cells. Circulation 118: 507-517, 2008.
80. Menasche P. Cardiac cell therapy: lessons from clinical trials. J Mol Cell Cardiol 50: 258-265, 2011.
81. Menasche P. Stem cell therapy for heart failure: are arrhythmias a real safety concern? Circulation 119: 2735-2740, 2009.
82. Min JY, Yang Y, Sullivan MF, Ke Q, Converso KL, Chen Y, Morgan JP, Xiao YF. Long-term improvement of cardiac function in rats after infarction by transplantation of embryonic stem cells. J Thorac Cardiovasc Surg 125: 361-369, 2003.
83. Miura K, Okada Y, Aoi T, Okada A, Takahashi K, Okita K, Nakagawa M, Koyanagi M, Tanabe K, Ohnuki M, Ogawa D, Ikeda E, Okano H, Ya-manaka S. Variation in the safety of induced plu-ripotent stem cell lines. Nat Biotechnol 27: 743-745, 2009.
84. Miyoshi N, Ishii H, Nagano H, Haraguchi N, Dewi DL, Kano Y, Nishikawa S, Tanemura M, Mimori K, Tanaka F, Saito T, Nishimura J, Takemasa I, Miz-ushima T, Ikeda M, Yamamoto H, Sekimoto M, Doki Y, Mori M. Reprogramming of mouse and human cells to pluripotency using mature microRNAs. Cell Stem Cell 8: 633-638, 2011.
85. Moretti A, Bellin M, Welling A, Jung CB, Lam JT, Bott-Flugel L, Dorn T, Goedel A, Hohnke C, Hof-mann F, Seyfarth M, Sinnecker D, Schomig A, Laugwitz KL. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N Engl J Med 363: 1397-1409, 2010.
86. Muller M, Fleischmann BK, Selbert S, Ji GJ, Endl E, Middeler G, Muller OJ, Schlenke P, Frese S, Wobus AM, Hescheler J, Katus HA, Franz WM. Selection of ventricular-like cardiomyocytes from ES cells in vitro. FASEB J 14: 2540-2548, 2000.
87. Mummery C, Ward-van Oostwaard D, Doeven-dans P, Spijker R, van den Brink S, Hassink R, van der Heyden M, Opthof T, Pera M, de la Riviere AB, Passier R, Tertoolen L. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 107: 2733-2740, 2003.
88. Murry CE, Keller G. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 132: 661-680, 2008.
89. Narazaki G, Uosaki H, Teranishi M, Okita K, Kim B, Matsuoka S, Yamanaka S, Yamashita JK. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation 118: 498-506, 2008.
90. Nelson TJ, Martinez-Fernandez A, Yamada S, Perez-Terzic C, Ikeda Y, Terzic A. Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation 120: 408-416, 2009.
91. Neumayer HH. Introducing everolimus (Certican) in organ transplantation: an overview of preclinical and early clinical developments. Transplantation 79: S72-75, 2005.
92. Ng SY, Wong CK, Tsang SY. Differential gene expressions in atrial and ventricular myocytes: insights into the road of applying embryonic stem cell-derived cardiomyocytes for future therapies. Am J Physiol Cell Physiol 299: C1234-C1249, 2010.
93. Nussbaum J, Minami E, Laflamme MA, Virag JA, Ware CB, Masino A, Muskheli V, Pabon L, Rei-necke H, Murry CE. Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J 21: 1345-1357, 2007.
94. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 448: 313-317, 2007.
95. Ott HC, Matthiesen TS, Goh SK, Black LD, Kren SM, Netoff TI, Taylor DA. Perfusion-decellular-ized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 14: 213-221, 2008.
96. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, Lerou PH, Lensch MW, Daley GQ. Re-programming of human somatic cells to pluripo-tency with defined factors. Nature 451: 141-146, 2008.
97. Puchner EM, Alexandrovich A, Kho AL, Hensen U, Schafer LV, Brandmeier B, Grater F, Grub-muller H, Gaub HE, Gautel M. Mechanoenzymat-ics of titin kinase. Proc Natl Acad Sci USA 105: 13385-13390, 2008.
98. Qyang Y, Martin-Puig S, Chiravuri M, Chen S, Xu H, Bu L, Jiang X, Lin L, Granger A, Moretti A, Caron L, Wu X, Clarke J, Taketo MM, Laugwitz KL, Moon RT, Gruber P, Evans SM, Ding S, Chien KR. The renewal and differentiation of Isl1 + cardiovascular progenitors are controlled by a Wnt/ beta-catenin pathway. Cell Stem Cell1: 165-179, 2007.
99. Sadek H, Hannack B, Choe E, Wang J, Latif S, Garry MG, Garry DJ, Longgood J, Frantz DE, Olson EN, Hsieh J, Schneider JW. Cardiogenic small molecules that enhance myocardial repair by stem cells. Proc Natl Acad Sci USA 105: 6063-6068, 2008.
100. Saga Y, Hata N, Kobayashi S, Magnuson T, Seldin MF, Taketo MM. MesP1: a novel basic helix-loop-helix protein expressed in the nascent mesodermal cells during mouse gastrulation. Development 122: 2769-2778, 1996.
101. Saga Y, Kitajima S, Miyagawa-Tomita S. Mesp1 expression is the earliest sign of cardiovascular development. Trends Cardiovasc Med 10: 345-352, 2000.
102. Saga Y, Miyagawa-Tomita S, Takagi A, Kitajima S, Miyazaki J, Inoue T. MesP1 is expressed in the heart precursor cells and required for the formation of a single heart tube. Development 126: 3437-3447, 1999.
103. Schenke-Layland K, Rhodes KE, Angelis E, Bu-tylkova Y, Heydarkhan-Hagvall S, Gekas C, Zhang R, Goldhaber JI, Mikkola HK, Plath K, Ma-cLellan WR. Reprogrammed mouse fibroblasts differentiate into cells of the cardiovascular and hematopoietic lineages. Stem Cells 26: 1537-1546, 2008.
104. Schultheiss TM, Xydas S, Lassar AB. Induction of avian cardiac myogenesis by anterior endoderm. Development 121: 4203-4214, 1995.
105. Sepulveda JL, Belaguli N, Nigam V, Chen CY, Nemer M, Schwartz RJ. GATA4 Nkx-2.5 coacti-vate Nkx-2 DNA binding targets: role for regulating early cardiac gene expression. Mol Cell Biol 18: 3405-3415, 1998.
106. Shiojima I, Komuro I, Mizuno T, Aikawa R, Aka-zawa H, Oka T, Yamazaki T, Yazaki Y. Molecular cloning and characterization of human cardiac homeobox gene CSX1. Circ Res 79: 920-929, 1996.
107. Singla DK, Hacker TA, Ma L, Douglas PS, Sullivan R, Lyons GE, Kamp TJ. Transplantation of embryonic stem cells into the infarcted mouse heart: formation of multiple cell types. J Mol Cell Car-diol 40: 195-200, 2006.
108. Singla DK, Lyons GE, Kamp TJ. Transplanted embryonic stem cells following mouse myocardial infarction inhibit apoptosis and cardiac remodeling. Am J Physiol Heart Circ Physiol 293: H1308-H1314, 2007.
109. Swijnenburg RJ, Schrepfer S, Govaert JA, Cao F, Ransohoff K, Sheikh AY, Haddad M, Connolly AJ, Davis MM, Robbins RC, Wu JC. Immunosuppres-sive therapy mitigates immunological rejection of human embryonic stem cell xenografts. Proc Natl Acad Sci USA 105: 12991-12996, 2008.
110. Swijnenburg RJ, Sheikh AY, Robbins RC. Comment on "Transplantation of undifferentiated murine embryonic stem cells in the heart: tera-toma formation and immune response". FASEB J 21: 1290; author reply 1291, 2007.
111. Swijnenburg RJ, Tanaka M, Vogel H, Baker J, Kofidis T, Gunawan F, Lebl DR, Caffarelli AD, de Bruin JL, Fedoseyeva EV, Robbins RC. Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium. Circulation 112: I166-I172, 2005.
112. Szabo E, Rampalli S, Risueno RM, Schnerch A, Mitchell R, Fiebig-Comyn A, Levadoux-Martin M, Bhatia M. Direct conversion of human fibroblasts to multilineage blood progenitors. Nature 468: 521-526, 2010.
113. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichi-saka T, Tomoda K, Yamanaka S. Induction of pluripotent stem cells from adult human fibro-blasts by defined factors. Cell 131: 861-872, 2007.
114. Takahashi K, Yamanaka S. Induction of pluripo-tent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676, 2006.
115. Takahashi T, Lord B, Schulze PC, Fryer RM, Sa-rang SS, Gullans SR, Lee RT. Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes. Circulation 107: 1912-1916, 2003.
116. Thayer MJ, Tapscott SJ, Davis RL, Wright WE, Lassar AB, Weintraub H. Positive autoregulation of the myogenic determination gene MyoD1. Cell 58: 241-248, 1989.
117. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. Embryonic stem cell lines derived from human blastocysts. Science 282: 1145-1147, 1998.
118. Tonissen KF, Drysdale TA, Lints TJ, Harvey RP, Krieg PAXNkx-2. 5,. a Xenopus gene related to Nkx-2.5 and tinman: evidence for a conserved role in cardiac development. Dev Biol 162: 325-328, 1994.
119. Tulloch NL, Muskheli V, Razumova MV, Korte FS, Regnier M, Hauch KD, Pabon L, Reinecke H, Murry CE. Growth of engineered human myocardium with mechanical loading and vascular cocul-ture. Circ Res 109: 47-59, 2011.
120. Tzahor E. Wnt/beta-catenin signaling and cardio-genesis: timing does matter. Dev Cell 13: 10-13, 2007.
121. Ventura C, Maioli M, Asara Y, Santoni D, Mesirca P, Remondini D, Bersani F. Turning on stem cell cardiogenesis with extremely low frequency magnetic fields. FASEB J 19: 155-157, 2005.
122. Vierbuchen T, Ostermeier A, Pang ZP, Kokubu Y, Sudhof TC, Wernig M. Direct conversion of fibro-blasts to functional neurons by defined factors. Nature 463: 1035-1041, 2010.
123. Voronov DA, Alford PW, Xu G, Taber LA. The role of mechanical forces in dextral rotation during cardiac looping in the chick embryo. Dev Biol 272: 339-350, 2004.
124. Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, Lau F, Ebina W, Mandal PK, Smith ZD, Meissner A, Daley GQ, Brack AS, Collins JJ, Cowan C, Sch-laeger TM, Rossi DJ. Highly efficient reprogram-ming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7: 618-630, 2010.
125. Wei L, Imanaka-Yoshida K, Wang L, Zhan S, Schneider MD, DeMayo FJ, Schwartz RJ. Inhibition of Rho family GTPases by Rho GDP dissociation inhibitor disrupts cardiac morphogenesis and inhibits cardiomyocyte proliferation. Development 129: 1705-1714, 2002.
126. Weintraub H, Tapscott SJ, Davis RL, Thayer MJ, Adam MA, Lassar AB, Miller AD. Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proc Natl Acad Sci USA 86: 5434-5438, 1989.
127. Wobus AM, Kaomei G, Shan J, Wellner MC, Ro-hwedel J, Ji G, Fleischmann B, Katus HA, Hes-cheler J, Franz WM. Retinoic acid accelerates embryonic stem cell-derived cardiac differentiation and enhances development of ventricular cardiomyocytes. J Mol Cell Cardiol 29: 1525-1539, 1997.
128. Woltjen K, Michael IP, Mohseni P, Desai R, Mil-eikovsky M, Hamalainen R, Cowling R, Wang W, Liu P, Gertsenstein M, Kaji K, Sung HK, Nagy A. PiggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458: 766-770, 2009.
129. Yamagishi H, Yamagishi C, Nakagawa O, Harvey RP, Olson EN, Srivastava D. The combinatorial activities of Nkx2.5 and dHAND are essential for cardiac ventricle formation. Dev Biol 239: 190-203, 2001.
130. Yamanaka S. Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 1: 39-49, 2007.
131. Yang L, Soonpaa MH, Adler ED, Roepke TK, Katt-man SJ, Kennedy M, Henckaerts E, Bonham K, Abbott GW, Linden RM, Field LJ, Keller GM. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 453: 524-528, 2008.
132. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA. Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920, 2007.
133. Zhang J, Wilson GF, Soerens AG, Koonce CH, Yu J, Palecek SP, Thomson JA, Kamp TJ. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 104: e30-e41, 2009.
134. Zhou H, Li W, Zhu S, Joo JY, Do JT, Xiong W, Kim JB, Zhang K, Scholer HR, Ding S. Conversion of mouse epiblast stem cells to an earlier pluripo-tency state by small molecules. J Biol Chem 285: 29676-29680, 2010.
135. Zhou H, Wu S, Joo JY, Zhu S, Han DW, Lin T, Trauger S, Bien G, Yao S, Zhu Y, Siuzdak G, Scholer HR, Duan L, Ding S. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4: 381-384, 2009.
136. Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 455: 627-632, 2008.
137. Zwi L, Caspi O, Arbel G, Huber I, Gepstein A, Park IH, Gepstein L. Cardiomyocyte differentiation of human induced pluripotent stem cells. Circulation 120: 1513-1523, 2009.